This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.
New marketing authorisations
TABLE 1: New marketing authorisations in October 2023
New Marketing Authorisations
|
Product name and target species
|
Active substance
|
Authorisation Holder, territory, and distribution category
|
Therapeutic group
|
Food Animals
|
Luteoplan 0.25 mg/ml Solution for Injection for Cattle and Horses
|
Cloprostenol
|
Syn Vet-Pharma Ireland Limited
GB & NI
POM-V
|
Prostaglandin
|
See the VMD’s Product Information Database (www.gov.uk/check-animal-medicine-licensed) for more information on each of these products. There may be a delay before formal documentation is available for some Northern Ireland products, from the European Medicines Agency.
The timing of the product being placed on the market is an issue for the marketing authorisation holder.